2 great growth stocks with stunning momentum

Royston Wild looks at two growth giants that could keep on surging.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Airplane sitting on a runway

The electric share price ascent at Bodycote (LSE: BOY) received a further shot in the arm in late February, as signs of progress in its key markets sent investors into something of a frenzy.

The engineer has now added 29% in value since the start of 2016, and I believe it has what it takes to surpass April’s all-time tops of 836.5p per share.

At first glance Bodycote’s full-year release in February may not have appeared much to shout about. While revenues rose 5.9% to £600.6m, the thermal processor manufacturer saw like-for-like sales slump 3.5%.

Still, stock pickers cheered news that “excluding energy, revenues at constant exchange rates were flat, with momentum building throughout the year.” Revenues at constant currencies were actually 6% lower at the mid-year point, illustrating Bodycote’s robust sales improvement more recently.

Rosy outlook

At its aviation operations, the engineer noted that “civil aerospace in Western Europe was strong [in 2016], particularly in the second half,” and it advised that it expects “continued modest growth” from its commercial division in 2017.

Not only does the prospect of rising civil build rates bode well for Bodycote’s aerospace operations, but President Trump’s desire to rebuild the US military could provide its defence arm a huge dose of rocket fuel too.

Meanwhile, a resolute auto market also provides Bodycote with strong sales opportunities. The firm saw car and light truck revenues growth double to 6% in the second half of 2016 from 3% in the prior six months, thanks to a strong global market and new contract successes.

So while uncertainty surrounding the oil and gas markets could remain a headache for Bodycote’s energy operations (the firm expects “no near-term improvement in the oil & gas sector”), I believe the structural opportunities afforded by its other core markets, allied with ongoing efforts to improve its business mix, should deliver strong earnings growth.

The City expects Bodycote to generate bottom-line expansion of 11% and 7% in 2017 and 2018 alone. So while looking slightly toppy on paper, I reckon a forward P/E ratio of 22.1 times is fair value given the engineer’s robust long-term outlook.

A delicious pick

Investors have also been piling into Hilton Food Group (LSE: HFG) with gusto over recent weeks, the stock gaining 15% during the past month alone and hitting new record tops around 750p in the process.

Hilton was buoyed by a positive reaction to late March’s full-year financials, with a strong performance in the UK driving volumes and like-for-like revenues 7.4% and 7.2% higher respectively in 2016. And the business has also been a beneficiary of heavy sterling weakness over the past year (at actual currencies sales rose 12.8% last year).

With the City expecting revenues to keep on rising, Hilton’s hot growth story is anticipated to continue with bottom-line expansion of 7% and 6% in 2017 and 2018.

Such forecasts result in a high prospective P/E multiple of 20.3 times. But I believe the huge investment Hilton is making to expand its international footprint should help deliver meaty earnings expansion and help it merit such a premium. For instance, work is due to start later this year on its most expensive investment to date, the colossal Queensland facility. 

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Bodycote. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Here’s how investors can aim for £11,363 a year in passive income from £20,000 in this overlooked FTSE media gem

I think this media stock is commonly overlooked by investors looking for high passive income, but it shouldn’t be, given…

Read more »